1. Home
  2. DRTS vs BRUN Comparison

DRTS vs BRUN Comparison

Compare DRTS & BRUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

N/A

Current Price

$13.40

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Logo Boost Run Inc. Class A Common Stock

BRUN

Boost Run Inc. Class A Common Stock

N/A

Current Price

$5.43

Market Cap

1.4B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
DRTS
BRUN
Founded
2015
2023
Country
Israel
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
2021
2026

Fundamental Metrics

Financial Performance
Metric
DRTS
BRUN
Price
$13.40
$5.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
4
Target Price
$20.60
★ $42.75
AVG Volume (30 Days)
502.7K
★ 3.8M
Earning Date
11-27-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$550.82
Revenue Next Year
$1,793.58
$214.84
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.43
$5.00
52 Week High
$15.79
$40.46

Technical Indicators

Market Signals
Indicator
DRTS
BRUN
Relative Strength Index (RSI) 47.69 34.23
Support Level $12.33 N/A
Resistance Level $13.95 $26.68
Average True Range (ATR) 0.64 0.87
MACD 0.06 0.17
Stochastic Oscillator 38.02 10.73

Price Performance

Historical Comparison
DRTS
BRUN

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

About BRUN Boost Run Inc. Class A Common Stock

Boost Run Inc is an NVIDIA Cloud Provider. Its platform provides GPU compute, CPU nodes, managed Kubernetes orchestration, and shared storage through an intuitive management console and a robust API layer, enabling organizations to provision and scale resources across thousands of nodes in minutes. Enterprises rely on Boost Run to power their main demanding AI workloads with the performance, security, and reliability their operations require. The group maintains SOC 2 Type II, HIPAA, ISO 27001, and ISO 27701 certifications at the operator level, and partners with data center facilities that uphold equivalent security and compliance standards.

Share on Social Networks: